The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2950649
WO Application Number:
US2014013992
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14746786.4
WO Publication Number:
WO2014120995
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
31/01/2014
Grant date:
04/03/2020
EP Publication Date:
09/12/2015
WO Publication Date:
07/08/2014
Claims Translations Received Date:
Claims Translation B1 Received Date:
08/05/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
04/03/2020
EP B1 Publication Date:
04/03/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
30/01/2034
Lapsed By Expiration Date:
Patent Validated Date:
15/05/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
18/06/2024
Name:
Pharma Cinq, LLC
Address:
1601 Research Boulevard, 20850, Rockville, Maryland, United States of America (US)
Historical Applicant/holder
From:
04/03/2020
To:
18/06/2024
Name:
Wellstat Therapeutics Corporation
Address:
14200 Shady Grove Road, Suite 600, Rockville, MD 20850, United States of America (US)
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995 in respect of which a decision has been taken. Oppositon(s) decisions ex European Patent Convention
3
Bulletin Heading:
VB1
Journal edition number:
46/23
Publication date:
15/11/2023
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention
4
Bulletin Heading:
VRV
Journal edition number:
36/23
Publication date:
06/09/2023
Description:
Lapse or annulment
5
Bulletin Heading:
EP3
Journal edition number:
21/20
Publication date:
20/05/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
6
Bulletin Heading:
EP2
Journal edition number:
10/20
Publication date:
08/05/2020
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
202010
Publication date:
04/03/2020
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202401099A
Date Registered:
18/06/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Pharma Cinq, LLC
Address:
1601 Research Boulevard, 20850, Rockville, Maryland, United States of America (US)